March 28 (Reuters) - The U.S. Food and Drug Administration approved French drugmaker ... shares of Paris-based Sanofi closed 1.7% higher. Sign up here. Sanofi's subcutaneous, or under-the-skin ...

Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...

“The FDA approval of VYKAT XR is an incredible achievement for the ... Read more stories like this one. Sign up for Disability Scoop's free email newsletter to get the latest developmental disability ...

New medicines are being developed for individual treatments based on someone’s DNA. Those would be allowed under a proposed ...

While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...

Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

Joining us today are Oncocyte President and CEO, Josh Riggs; Chief Science Officer, Ekke Schutz; and CFO, Andrea James. We ...

Synthetic dyes used to make brightly colored cereals, drinks and candies are coming under scrutiny in states across the ...

Q4 2024 Earnings Conference Call March 24, 2025 5:00 PM ETCompany ParticipantsGabby Woody - Executive Assistant, ...

The new framework aims to shorten the time on register new medications in Israel, making drugs more readily available to the ...

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...